LINAFEXOR Trademark
Trademark Overview
On Tuesday, May 27, 2025, a trademark application was filed for LINAFEXOR with the United States Patent and Trademark Office. The USPTO has given the LINAFEXOR trademark a serial number of 79427316. The federal status of this trademark filing is REGISTERED as of Tuesday, May 26, 2026. This trademark is owned by Cascade Pharmaceuticals, Inc. The LINAFEXOR trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical drugs for medical purposes for the treatment of Metabolic diseases and Inflammation; organotherapy preparations; biological preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; medicines for human purposes for the treatment of Metabolic diseases and Inflammation; chemical preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes
General Information
| Serial Number | 79427316 |
| Word Mark | LINAFEXOR |
| Filing Date | Tuesday, May 27, 2025 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 26, 2026 |
| Registration Number | 8268547 |
| Registration Date | Tuesday, May 26, 2026 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 7, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical drugs for medical purposes for the treatment of Metabolic diseases and Inflammation; organotherapy preparations; biological preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; medicines for human purposes for the treatment of Metabolic diseases and Inflammation; chemical preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 10, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Cascade Pharmaceuticals, Inc |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Cascade Pharmaceuticals, Inc |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Cascade Pharmaceuticals, Inc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
Trademark Events
| Event Date | Event Description |
| Thursday, July 10, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, July 11, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 11, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, August 21, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, August 27, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, August 28, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, October 13, 2025 | REFUSAL PROCESSED BY MPU |
| Monday, October 13, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, October 31, 2025 | REFUSAL PROCESSED BY IB |
| Friday, March 13, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 13, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 13, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, March 15, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 1, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 7, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 7, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 26, 2026 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 26, 2026 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, May 26, 2026 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, May 26, 2026 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
